Liminatus Pharma, Inc. (LIMN)

0.8752 +0.01 (+1.30%) USD  |  NASDAQ  |  Dec 09, 16:00
0.8425 -0.03 (-3.74%) After-Hours: 20:00
More

Liminatus Pharma Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for LIMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
CDT Equity, Inc. Upgrade
LENZ Therapeutics, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
Maze Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. --

Return on Net Operating Assets Related Metrics

Return on Assets Upgrade